Duchenne muscular dystrophy is a congenital disease that affects boys almost exclusively (“Jerry’s kids“) and leads to severe muscle dysfunction and death. Current therapies, primarily corticosteroids, are very limited in effectiveness – and introduce their own side effects that can make things worse. Now researchers at Washington University School of Medicine in St. Louis are reporting on a new technique that involves introducing nanoparticles – stuffed with rapamycin – to alleviate some of the symptoms of the disease.
Hey, check out all the research scientist jobs. Post your resume today!
